Back to search results
NCT07655232

Pilot Study of a Behavioral Program for Resident Depression in Skilled Nursing Facilities

Recruiting
NAAges 18+InterventionalTreatment
Massachusetts General Hospital
~20 participants
Updated 2026-06-17 on ClinicalTrials.gov
What's tested:Interventions for Stressful Transitions in Later Life (InSTILL) for Individuals

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mean Total Score Treatment Credibility
Measured over After session 1 of intervention, an average of 1 week after baseline
+8 more outcomes measured

Conditions

Nursing Home Resident
Skilled Nursing Facility
Depression
Feasibility Studies

Explore related trials

Depression

Where it's being run

1 sites across 1 states
Massachusetts1

Study leadership

  • Evan Plys, PhD · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital

Who to contact

BRISK Study Coordinator
[email protected]
617-643-9406
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Psychological distress, as indicated by a score Patient Health Questionnaire- 2 ≥ 2 OR Patient Health Questionnaire-9 ≥ 5
5+ chronic conditions based on Elixhauser Comorbidity Index
Aged ≥ 18 years
Able and willing to participate in the study

Exclusion

Intended length of SNF stay \< 7 days
More than mild cognitive impairment, as indicted by Brief Interview for Mental Status (BIMS) \<13
Participant's roommate is already enrolled in study/intervention
High risk of suicide/active documented SI per the PHQ-9, item 9 or otherwise
Participation in newly initiated psychotherapy

What this trial measures

  • Mean Total Score Treatment CredibilityAfter session 1 of intervention, an average of 1 week after baseline

    3-item self-report measure of participant's belief regarding how helpful the intervention will be for them. Higher scores (min = 0, max = 30) scores indicate greater credibility.

  • Mean Total Score Client Satisfaction QuestionnairePost intervention, an average of 4 weeks after baseline

    3-item self-report measure assessing patient satisfaction with the program. Higher total scores (min = 3, max = 12) indicate greater satisfaction.

  • Percentage of Eligible Participants EnrolledPost intervention, an average of 4 weeks after baseline

    Percentage of eligible approached individuals that are enrolled into the study.

  • Percentage of Participants with Missing Data4 weeks after post-intervention

    Percentage of all participants with no measure fully missing at 4-week follow-up.

  • Attendance RatePost intervention, an average of 4 weeks after baseline

    Percentage of participants completing 4/6 sessions of the intervention.

  • Clinician FidelityPost intervention, an average of 4 weeks after baseline

    Percentage of InSTILL sessions delivered with 100% adherence on a study-specific Fidelity Checklist, based on those randomly sampled to be assessed.

  • Number of Adverse Events4 weeks after post-intervention

    Number of adverse events related to participation in the study.

  • Treatment Acceptability SurveyPost intervention, an average of 4 weeks after baseline

    Percentage of participants scoring above the scale midpoint on all Treatment Acceptability Survey items (developed for the current study).

  • Percentage of Participants Meeting Participant Comprehension CriterionPost intervention, an average of 4 weeks after baseline

    Percentage of participants scoring 7+ on a single-item cognitive load question (min=0, max=10)